Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis
Status
Conditions
Treatments
Details and patient eligibility
About
Periodontitis (PD) has been postulated to be a risk factor for the onset and progression of rheumatoid arthritis (RA). Recent reports suggest that infection with Porphyromonas gingivalis (P. gingivalis), a major oral pathogen in PD, could play a pivotal role in the development RA. The objective of this study is to examine the relationship of PD and P. gingivalis infection with the risk and severity of RA.
Full description
In this study, we will examine whether periodontitis (PD) and P. gingivalis impact rheumatoid arthritis (RA) risk by enrolling 300 patients with RA and 300 comparator patients with osteoarthritis and comparing results from comprehensive dental examinations and antibody responses to P. gingivalis. We will examine whether these associations are modified by the presence of certain genetic risk factors previously implicated in RA and whether evidence of infection with P. gingivalis precedes RA onset by examining banked sera from the Department of Defense Serum Repository (DoDSR) and the Studies of the Etiology of RA (SERA). We also plan to explore whether there are novel proteins expressed by P. gingivalis that drive autoimmunity in RA and whether immune responses to these bacterial proteins predict the future development of RA.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age 19 years or older
- Diagnosis of rheumatoid arthritis, or osteoarthritis
- Have 9 or more evaluable posterior teeth (out of a total of 28 teeth, excluding third molars)
- Willing and able to provide informed consent
Exclusion criteria
- Received tetracyclines within the last 6 months.
- Need for antibiotic premedication for dental probing.
- Pregnant or breast feeding
Trial design
617 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal